Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.18632/oncoscience.357 http://scihub22266oqcxt.onion/10.18632/oncoscience.357 C5616202!5616202 !28966942     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=28966942 &cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\28966942 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Oncoscience 2017 ; 4 (7-8 ): 95-105 Nephropedia Template TP {{tp|p=28966942 |t=2017. Beta-adrenergic receptors are expressed across diverse cancers |pdf=|usr=}}{{28966942 }} gab.com Text Beta-adrenergic receptors are expressed across diverse cancers JO: Oncoscience http://www.kidney.de/pget.php?&tw=1&pmid=28966942 #FOAvip Based largely on retrospective analyses and a handful of prospective case reports, pharmacological inhibition of the beta adrenergic receptors using beta blockers has shown clinical anti-cancer efficacy in reproductive cancers, as well as angiosarcoma and multiple myeloma. Because of the potential promise of beta blockers as an adjunct to standard anti-cancer therapy, it is imperative to identify other tumor types expressing beta adrenergic (?-AR) receptors so future preclinical and clinical studies can be directed at the most promising tumor targets. We performed immunohistochemical detection of ?1-AR, ?2-AR, and ?3-AR across 29 of the most common human cancer types (389 tissues total) and 19 matching non-diseased controls (100 tissues total). Our analysis revealed all three ?-AR receptors were expressed most strongly in melanoma relative to other cancer types. Other malignancies that revealed relatively higher levels of ?-AR receptors were esophagus, pancreas, kidney, and lung cancers. Moreover, particular ?-AR receptors exhibited significant overexpression in tumor tissue relative to their matching normal tissue in urogenital/reproductive malignancies including breast, endometrium, ovarian, and urothelial cancer, as well as colon, lung, and thyroid cancer. This study identifies several cancer types expressing the ?-AR receptors which should be evaluated in future studies for susceptibility to beta blockade. Twit Text FOAVip Beta-adrenergic receptors are expressed across diverse cancers ????Oncoscience http://www.kidney.de/pget.php?&tw=1&pmid=28966942 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28966942 #FOAvip English Wikipedia <ref>{{Cite pmid|28966942 }}</ref> Beta-adrenergic receptors are expressed across diverse cancers #MMPMID28966942 Rains SL ; Amaya CN ; Bryan BA Oncoscience 2017[Jul]; 4 (7-8 ): 95-105 PMID28966942 show ga Based largely on retrospective analyses and a handful of prospective case reports, pharmacological inhibition of the beta adrenergic receptors using beta blockers has shown clinical anti-cancer efficacy in reproductive cancers, as well as angiosarcoma and multiple myeloma. Because of the potential promise of beta blockers as an adjunct to standard anti-cancer therapy, it is imperative to identify other tumor types expressing beta adrenergic (?-AR) receptors so future preclinical and clinical studies can be directed at the most promising tumor targets. We performed immunohistochemical detection of ?1-AR, ?2-AR, and ?3-AR across 29 of the most common human cancer types (389 tissues total) and 19 matching non-diseased controls (100 tissues total). Our analysis revealed all three ?-AR receptors were expressed most strongly in melanoma relative to other cancer types. Other malignancies that revealed relatively higher levels of ?-AR receptors were esophagus, pancreas, kidney, and lung cancers. Moreover, particular ?-AR receptors exhibited significant overexpression in tumor tissue relative to their matching normal tissue in urogenital/reproductive malignancies including breast, endometrium, ovarian, and urothelial cancer, as well as colon, lung, and thyroid cancer. This study identifies several cancer types expressing the ?-AR receptors which should be evaluated in future studies for susceptibility to beta blockade. äBeta-adrenergic receptors are expressed across diverse cancers (epmc).pdf DeepDyve Pubget Overpricing